TLDR Krispy Kreme stock jumped 14% on October 21, closing around $3.71, but remains down 65% year-to-date after falling from over $12 in late 2024. The company ended its unprofitable McDonald’s USA partnership in July 2025, which caused a 21% revenue drop in the U.S. segment as it exited 2,400 locations. Q2 2025 showed revenue [...] The post Krispy Kreme (DNUT) Stock: Doughnut Chain Sees 14% Pop on International Expansion appeared first on Blockonomi.TLDR Krispy Kreme stock jumped 14% on October 21, closing around $3.71, but remains down 65% year-to-date after falling from over $12 in late 2024. The company ended its unprofitable McDonald’s USA partnership in July 2025, which caused a 21% revenue drop in the U.S. segment as it exited 2,400 locations. Q2 2025 showed revenue [...] The post Krispy Kreme (DNUT) Stock: Doughnut Chain Sees 14% Pop on International Expansion appeared first on Blockonomi.

Krispy Kreme (DNUT) Stock: Doughnut Chain Sees 14% Pop on International Expansion

TLDR

  • Krispy Kreme stock jumped 14% on October 21, closing around $3.71, but remains down 65% year-to-date after falling from over $12 in late 2024.
  • The company ended its unprofitable McDonald’s USA partnership in July 2025, which caused a 21% revenue drop in the U.S. segment as it exited 2,400 locations.
  • Q2 2025 showed revenue fell 13.5% to $379.8 million with a $441.1 million GAAP loss, largely from $406.9 million in impairment charges.
  • Management launched a four-part turnaround plan focused on refranchising international markets, cutting costs, and targeting high-volume U.S. channels.
  • The company opened its first Spain location on October 2 and plans expansion in Brazil and Uzbekistan, with over 50 Spanish stores planned in four years.

Krispy Kreme shares jumped roughly 14% on October 21, closing around $3.71. The pop comes after months of declines that saw the stock drop 65% year-to-date.


DNUT Stock Card
Krispy Kreme, Inc., DNUT

The recent rally follows news of the company’s international expansion efforts. But the celebrations might be premature.

The doughnut chain faces serious headwinds at home. Q2 2025 results showed revenue fell 13.5% year-over-year to $379.8 million.

The company posted a massive GAAP net loss of $441.1 million. Most of that came from $406.9 million in impairment charges.

U.S. sales took the biggest hit. Revenue in the domestic segment dropped 21% compared to last year.

The McDonald’s partnership collapse explains much of the pain. Krispy Kreme and McDonald’s USA ended their doughnut deal on July 2, 2025.

CEO Josh Charlesworth said the McDonald’s outlets proved unprofitable. The company exited roughly 2,400 locations.

The international picture looks brighter. Sales outside the U.S. grew about 6% from last year.

Canada, Japan, and Mexico showed strength. That’s where management is placing its bets now.

Turnaround Strategy Takes Shape

Management rolled out a four-part plan on August 7, 2025. The strategy aims to fix the balance sheet and restart growth.

First, the company will refranchise owned markets and restructure joint ventures. Second, it plans to improve returns by using existing assets better.

Third, Krispy Kreme will cut costs by outsourcing U.S. logistics. Fourth, it will focus U.S. growth on high-volume, high-margin channels.

Charlesworth told investors the company expects to start recovering profitability in Q3. He emphasized a two-pronged approach.

The plan calls for “profitable U.S. expansion and capital-light international franchise growth.” That’s corporate speak for doing more with less money.

The company also shuffled its leadership team. Raphael Duvivier became CFO in July after serving as President of International.

Longtime growth executive David Skena departed. Alison Holder moved into an expanded brand role.

The changes reflect a renewed focus on marketing and product innovation. Management clearly thinks fresh faces might help.

Global Push Accelerates

Krispy Kreme opened its first Spanish shop in Madrid on October 2. Local franchisee Glaseados Originales partnered on the launch.

Two more Madrid locations are planned by year-end. The company targets over 50 Spanish stores in the next four years.

Brazil is also getting attention. Two new São Paulo outlets are coming via a joint venture.

Uzbekistan represents totally new territory. The first shop in Tashkent is set for October 2025.

The company now operates in over 40 countries. These moves aim to tap emerging demand for fresh doughnuts.

Morgan Stanley called out Krispy Kreme as the top-performing restaurant stock in Q3. The stock gained 33% during that period.

But the investment firm maintained its ‘Underweight’ rating. Its price target of $2.50 implies a 33% downside from current levels.

The average analyst price target sits around $6.45. That’s well above the current price but far below historic highs.

Zacks recently moved to “strong sell” while JPMorgan stuck with underweight. Most analysts rate the stock around “hold.”

The recent stock jump looks driven by retail momentum rather than fundamentals. Some analysts compared it to 2021’s meme-stock craze.

The post Krispy Kreme (DNUT) Stock: Doughnut Chain Sees 14% Pop on International Expansion appeared first on Blockonomi.

Market Opportunity
Zypher Network Logo
Zypher Network Price(POP)
$0.0006305
$0.0006305$0.0006305
-0.64%
USD
Zypher Network (POP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23